ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

Eight applications Received For NSABP chairman

September 9, 1994

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011